Clinical Trial Update: B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update assessing B cell response to a primary and booster course of the Novartis meningococcal ACWY conjugate vaccine in healthy infants;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• Meningococcal ACWY Conjugate Vaccine (Novartis) (Meningococcal conjugate vaccine for serogroups A, C, W, and Y)

Snippet

Sponsor: Novartis Vaccines | Conditions: Meningococcal Disease | Phase 2 | Status: COMPLETED | Results posted: 2014-08-15